Mats Hidestrand

2.2k total citations
40 papers, 1.8k citations indexed

About

Mats Hidestrand is a scholar working on Pharmacology, Oncology and Surgery. According to data from OpenAlex, Mats Hidestrand has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 10 papers in Oncology and 8 papers in Surgery. Recurrent topics in Mats Hidestrand's work include Pharmacogenetics and Drug Metabolism (20 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Mats Hidestrand is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Mats Hidestrand collaborates with scholars based in United States, Sweden and Italy. Mats Hidestrand's co-authors include Magnus Ingelman‐Sundberg, Mikael Oscarson, Gunnel Tybring, Inger Johansson, Pippa Simpson, Erik Eliasson, Ümit Yaşar, Brith Leidvik, Christer von Bahr and Thomas M. Badger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Mats Hidestrand

40 papers receiving 1.7k citations

Peers

Mats Hidestrand
Ajay Madan United States
S. Cholerton United Kingdom
Rebecca Blanchard United States
Mats Hidestrand
Citations per year, relative to Mats Hidestrand Mats Hidestrand (= 1×) peers Alvin Gomez

Countries citing papers authored by Mats Hidestrand

Since Specialization
Citations

This map shows the geographic impact of Mats Hidestrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Hidestrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Hidestrand more than expected).

Fields of papers citing papers by Mats Hidestrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Hidestrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Hidestrand. The network helps show where Mats Hidestrand may publish in the future.

Co-authorship network of co-authors of Mats Hidestrand

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Hidestrand. A scholar is included among the top collaborators of Mats Hidestrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Hidestrand. Mats Hidestrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richmond, Marc E., Steven Zangwill, Steven J. Kindel, et al.. (2019). Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. The Journal of Heart and Lung Transplantation. 39(5). 454–463. 62 indexed citations
2.
Stamm, Karl, Mats Hidestrand, Huan Liang, et al.. (2018). NOVEL ASSAY TO CALCULATE DONOR FRACTION OF CELL-FREE DNA IN HEART TRANSPLANTATION. Journal of the American College of Cardiology. 71(11). A764–A764. 2 indexed citations
3.
Mitchell, Michael E., et al.. (2018). Metakaryotic cells linked to pediatric pulmonary vein stenosis. Cardiovascular Pathology. 39. 51–53. 5 indexed citations
4.
Hidestrand, Mats, Karl Stamm, Aoy Tomita‐Mitchell, et al.. (2013). Quantification of Circulating Donor Specific Cell Free DNA Is an Exquisitely Sensitive Non-Invasive Indicator of Injury to the Donor Heart. The Journal of Heart and Lung Transplantation. 32(4). S101–S102. 1 indexed citations
5.
Hidestrand, Mats, Renee Stokowski, Ken Song, et al.. (2012). Influence of Temperature during Transportation on Cell-Free DNA Analysis. Fetal Diagnosis and Therapy. 31(2). 122–128. 57 indexed citations
6.
Mitchell, Michael E., Mats Hidestrand, Pippa Simpson, et al.. (2010). Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms. PLoS ONE. 5(10). e13184–e13184. 15 indexed citations
7.
Hidestrand, Mats, Cathy M. Gurley, Greg T. Nolen, et al.. (2008). Sca-1-Expressing Nonmyogenic Cells Contribute to Fibrosis in Aged Skeletal Muscle. The Journals of Gerontology Series A. 63(6). 566–579. 37 indexed citations
8.
Chen, Jin‐Ran, Mats Hidestrand, Kartik Shankar, et al.. (2006). Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-κB Ligand in Osteoblasts. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1182–1190. 53 indexed citations
9.
Hidestrand, Mats, Kartik Shankar, Martin J. J. Ronis, & Thomas M. Badger. (2005). Effects of Light and Dark Beer on Hepatic Cytochrome P-450 Expression in Male Rats Receiving Alcoholic Beverages as Part of Total Enteral Nutrition. Alcoholism Clinical and Experimental Research. 29(5). 888–895. 16 indexed citations
10.
Bogni, Alessia, Mario Monshouwer, Mats Hidestrand, et al.. (2005). Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles. Toxicology in Vitro. 19(5). 621–629. 47 indexed citations
11.
Keizers, Peter H. J., Chris de Graaf, Mats Hidestrand, et al.. (2005). The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent. Biochemical Pharmacology. 70(8). 1253–1261. 30 indexed citations
12.
Badger, Thomas M., Mats Hidestrand, Kartik Shankar, W. David McGuinn, & Martin J. J. Ronis. (2005). The effects of pregnancy on ethanol clearance. Life Sciences. 77(17). 2111–2126. 28 indexed citations
13.
Vidali, Matteo, Mats Hidestrand, Erik Eliasson, et al.. (2004). Use of Molecular Simulation for Mapping Conformational CYP2E1 Epitopes. Journal of Biological Chemistry. 279(49). 50949–50955. 13 indexed citations
14.
Griškevičius, Laimonas, Ümit Yaşar, Mia Sandberg, et al.. (2003). Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes. European Journal of Clinical Pharmacology. 59(2). 103–109. 61 indexed citations
15.
Salonen, Jarmo S., Leena Nyman, Alan R. Boobis, et al.. (2003). COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS. Drug Metabolism and Disposition. 31(9). 1093–1102. 55 indexed citations
16.
Aklillu, Eleni, Mikael Oscarson, Mats Hidestrand, et al.. (2002). Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population. Molecular Pharmacology. 61(3). 586–594. 110 indexed citations
17.
Pelkonen, Olavi, Päivi Myllynen, Päivi Taavitsainen, et al.. (2001). Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derivedin vitrosystems. Xenobiotica. 31(6). 321–343. 49 indexed citations
18.
Facciolà, Gabriella, Mats Hidestrand, Christer von Bahr, & Gunnel Tybring. (2001). Cytochrome P 450 isoforms involved in melatonin metabolism in human liver microsomes. European Journal of Clinical Pharmacology. 56(12). 881–888. 102 indexed citations
19.
Bylund, Johan, Mats Hidestrand, Magnus Ingelman‐Sundberg, & Ernst H. Oliw. (2000). Identification of CYP4F8 in Human Seminal Vesicles as a Prominent 19-Hydroxylase of Prostaglandin Endoperoxides. Journal of Biological Chemistry. 275(29). 21844–21849. 75 indexed citations
20.
McLellan, Roman A., Mikael Oscarson, Mats Hidestrand, et al.. (2000). Characterization and Functional Analysis of Two Common Human Cytochrome P450 1B1 Variants. Archives of Biochemistry and Biophysics. 378(1). 175–181. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026